Group One Trading
CERE

Group One Trading’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Group One Trading’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-69,000
Closed -$2.82M – 7598
2024
Q2 		$2.82M Sell
69,000
-2,800
-4% -$117K 0.01% 1183
2024
Q1 		$3.03M Sell
71,800
-52,500
-42% -$2.21M 0.01% 1176
2023
Q4 		$5.27M Sell
124,300
-57,700
-32% -$1.66M 0.01% 1100
2023
Q3 		$3.97M Buy
182,000
+68,700
+61% +$1.72M 0.01% 1089
2023
Q2 		$3.6M Buy
113,300
+76,700
+210% +$2.35M 0.01% 1221
2023
Q1 		$893K Sell
36,600
-56,400
-61% -$1.66M ﹤0.01% 2234
2022
Q4 		$2.93M Buy
93,000
+62,900
+209% +$1.77M 0.01% 1510
2022
Q3 		$851K Buy
30,100
+27,100
+903% +$807K ﹤0.01% 2736
2022
Q2 		$79K Sell
3,000
-8,700
-74% -$247K ﹤0.01% 5197
2022
Q1 		$410K Sell
11,700
-77,100
-87% -$2.25M ﹤0.01% 4036
2021
Q4 		$2.88M Sell
88,800
-25,000
-22% -$882K ﹤0.01% 2224
2021
Q3 		$3.36M Buy
+113,800
New +$3.19M ﹤0.01% 2119

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Group One Trading's CERE Position: Q3 2024 in Review

Group One Trading sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 23,041 shares — an estimated $942K sold.

Group One Trading first reported a position in CERE in Q2 2022 and held it in 4 quarters. The position peaked at $1.14M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Group One Trading reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 23,041 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $942K.
  • Group One Trading first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Group One Trading's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.14M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.